» Articles » PMID: 4121701

Chemotactic Factor Inactivator in Normal Human Serum

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1973 May 1
PMID 4121701
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Normal human serum contains an inactivator of chemotactic factors for neutrophilic leukocytes. The chemotactic factor inactivator (CF-I) remains soluble when serum is fractionated with ammonium sulfate (at 45% saturation), directly and irreversibly inactivates chemotactic factors, and it has a broad spectrum of activity as indicated by its inactivation of the chemotactic fragments of human C3 and C5 (third and fifth components of complement), C567, and the bacterial chemotactic factor derived from Escherichia coli. CF-I appears as a biphasic activity according to preparative techniques of sucrose density ultracentrifugation, electrophoresis, and gel filtration. Studies on the interaction of CF-I with the radiotagged C5 chemotactic fragment fail to reveal evidence for irreversible binding as the basis for inactivation. CF-I varies from the anaphylatoxin inactivator in several physical-chemical respects, but evidence does not permit a conclusive statement about the relationship of the two inactivators. CF-I may function as a regulator of inflammatory responses.

Citing Articles

Immunological studies of anergic patients.

Van Epps D, Frierson J, Williams R Infect Immun. 1974; 10(5):1003-9.

PMID: 16558080 PMC: 423052. DOI: 10.1128/iai.10.5.1003-1009.1974.


Neutrophil chemotaxis dysfunction in human periodontitis.

Van Dyke T, Horoszewicz H, Cianciola L, Genco R Infect Immun. 1980; 27(1):124-32.

PMID: 7358424 PMC: 550734. DOI: 10.1128/iai.27.1.124-132.1980.


Monocyte count, monocyte chemotaxis and chemotactic factor inactivator in gastric cancer patients.

Yamane T, Sakita M, Kasuga M, Nishioka B, Fujita Y, Majima S Jpn J Surg. 1981; 11(6):422-7.

PMID: 7328934 DOI: 10.1007/BF02469025.


In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique.

DAmelio R, Rossi P, Le Moli S, Ricci R, Montano S, Pallone F Gut. 1981; 22(7):566-70.

PMID: 7262631 PMC: 1419327. DOI: 10.1136/gut.22.7.566.


Reduction of carrageenan- bradykinin- and histamine-induced acute inflammation by experimental eosinophilia in rats.

Popper H, Picher O, Auer H Immunology. 1982; 46(3):589-94.

PMID: 7095830 PMC: 1555312.


References
1.
Mullereberhard H, Dalmasso A, Calcott M . The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis. J Exp Med. 1966; 123(1):33-54. PMC: 2138124. DOI: 10.1084/jem.123.1.33. View

2.
Ward P, Cochrane C, MULLER-EBERHARD H . Further studies on the chemotactic factor of complement and its formation in vivo. Immunology. 1966; 11(2):141-53. PMC: 1423772. View

3.
Erdos E . Hypotensive peptides: bradykinin, kallidin, and eledoisin. Adv Pharmacol (1962). 1966; 4:1-90. DOI: 10.1016/s1054-3589(08)60097-6. View

4.
Cochrane C, MULLER-EBERHARD H . The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J Exp Med. 1968; 127(2):371-86. PMC: 2138443. DOI: 10.1084/jem.127.2.371. View

5.
Ward P, Lepow I, Newman L . Bacterial factors chemotactic for polymorphonuclear leukocytes. Am J Pathol. 1968; 52(4):725-36. PMC: 2013377. View